Physician profile
Zaher Hamadeh
NPI 1043226251
$18,990.76
in general payments reported to CMS, 2019-2025
14 companies · $1,918 in 2025
The $1,918 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,118 · 2020: $127 · 2021: $1,587 · 2022: $1,753 · 2023: $8,950 · 2024: $3,537 · 2025: $1,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,500 · Travel and Lodging: $1,990 · Food and Beverage: $1,815 · Consulting Fee: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,500.00 |
| Travel and Lodging | $1,990.13 |
| Food and Beverage | $1,815.08 |
| Consulting Fee | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,280.75 | 2021-2025 | Ellipsys Vascular Access System, Palindrome |
| Merit Medical Systems INC | $2,088.73 | 2022-2025 | Dialysis Catheter |
| Bard Peripheral Vascular, INC. | $1,921.27 | 2019-2025 | Covera, Venovo, Pristine |
| Mozarc Medical US LLC | $165.19 | 2023-2024 | Chameleon, Palindrome |
| Philips North America LLC | $161.56 | 2019-2022 | |
| Becton, Dickinson and Company | $112.73 | 2023-2024 | Pristine, Venovo |
| Vifor Pharma, INC. | $107.98 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $30.73 | 2020 | |
| Horizon Therapeutics Plc | $28.44 | 2023 | Krystexxa |
| Covidien LP | $26.36 | 2019-2020 | |
| Boston Scientific Corporation | $20.29 | 2021 | |
| Cook Medical LLC | $16.33 | 2020 | |
| Cardiovascular Systems INC. | $15.95 | 2019 | |
| Biotronik INC. | $14.45 | 2023 | Pulsar-18 T3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaher Hamadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.